Cargando…
Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
A paradigm-shift in the management of non-small cell lung cancer (NSCLC) has resulted in many new therapies becoming available for patients with advanced disease. Stratification of treatment by histologic and molecular subtype is recommended to obtain the greatest clinical benefit for patients while...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170132/ https://www.ncbi.nlm.nih.gov/pubmed/25295228 http://dx.doi.org/10.3389/fonc.2014.00258 |